CXCR4 and central nervous system cancer: The C-X-C Motif Chemokine Receptor 4 (CXCR4), the receptor for SDF-1, which promotes EMT in several cancers, has been shown to increase the expression of MES genes in glioma cell lines and its higher expression correlates with significantly reduced survival in GBM [95].